Prismocitrate 18, PrisMax System Version 3.x with calcium line accessory — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-12 (month) in 2mo
ESTIMATED |
READOUT
Safety Evaluation of Prismocitrate 18 in Patients Receiving CRRT
Phase 3 · Regional Citrate Anticoagulation (RCA), Continuous Renal Replacement Therapy (CRRT) |
Vantive Health LLC | Prismocitrate 18, PrisMax System Version |
ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
|